Gene · 7357
Papers2,116
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,116
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Glucosylceramide synthase is required for C6-ceramide nanoliposome-induced organelle stress and cell death. | bioRxiv | 2026 | 42818015 | PubTator, text mining | PubMed |
| Machine Learning-Guided Multi-Omics Integration Identifies UGCG as a Candidate Lipid Metabolic Biomarker and Potential Therapeutic Target in Sepsis. | J Inflamm Res | 2026 | 42808034 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomic Profiling Identifies B Cell-Intrinsic Dysregulation of Sphingolipid Biosynthesis and Could Be Improved by Inhibiting UGCG in Primary Immune Thrombocytopenia. | Adv Sci (Weinh) | 2026 | 42801631 | PubTator, text mining | PubMed |
| Miglustat in Neuronopathic Lysosomal Storage Disorders: Biological Rationale, Clinical Evidence, and Limits of Repurposing. | Int J Mol Sci | 2026 | 42794762 | PubTator, text mining | PubMed |
| Measles virus reprograms CD4+ T-cell sphingolipid and fatty acid metabolism to facilitate infection. | Front Cell Dev Biol | 2026 | 42688487 | PubTator, text mining | PubMed |
| A 16 × 8 Focused Compound Library Comprising All Configurational Isomers of the Archetypal Iminosugar, 1-Deoxynojirimycin. | J Med Chem | 2026 | 42679158 | PubTator, text mining | PubMed |
| Primate-specific regulation of the human glycosphingolipid gatekeeper UGCG. | Nature | 2026 | 42649293 | PubTator, text mining | PubMed |
| Roles of Ceramide Glucosyltransferase in Controlling Cerebral Microvascular Endothelial Integrity and Angiogenesis Post-Ischemia/Reperfusion. | Transl Stroke Res | 2026 | 42625084 | PubTator, text mining | PubMed |
| Glycosphingolipids are essential entry factors for non-influenza orthomyxoviruses. | J Gen Virol | 2026 | 42593847 | PubTator, text mining | PubMed |
| Integrated Multi-Omics Analysis Uncovers Molecular Dysregulation in Glucosylceramide Synthase-Deficient Human Induced Pluripotent Stem Cells. | Mol Cell Proteomics | 2026 | 42492790 | PubTator, text mining | PubMed |
| Novel treatments for Parkinson's disease. | Chin Med J (Engl) | 2026 | 42366511 | PubTator, text mining | PubMed |
| Novel Perspective for Prognostic Stratification and Personalized Therapy in Breast Cancer Patients: Development of Cancer Stem Cells and Metabolism-Associated Prognostic Model. | Int J Womens Health | 2026 | 42358344 | PubTator, text mining | PubMed |
| Off-Target Binding of Miglustat to Glycogen Debranching Enzyme. | Int J Mol Sci | 2026 | 42353206 | PubTator, text mining | PubMed |
| Patient-specific midbrain organoids with CRISPR correction recapitulate neuronopathic Gaucher disease phenotypes and enable evaluation of novel therapies. | Elife | 2026 | 42334452 | PubTator, text mining | PubMed |
| Therapeutic potential of the sphingosine kinase 2 inhibitor opaganib. | Pharm Sci Adv | 2026 | 42256552 | PubTator, text mining | PubMed |
| Suppression of Glucosylceramide Synthase Reverses Drug Resistance in Cancer Cells Harboring Homozygous p53 Mutants. | Int J Mol Sci | 2026 | 41977417 | PubTator, text mining | PubMed |
| From molecular mechanisms of glycosphingolipid function to bio-therapeutic applications. | Cell Mol Life Sci | 2026 | 41904721 | PubTator, text mining | PubMed |
| The dual impact of GBA1 in disease: from germline mutations in neurological disorders to alterations in cancer. | Cell Death Discov | 2026 | 41857000 | PubTator, text mining | PubMed |
| Glycolipid transfer protein modulates vesicular trafficking from the endoplasmic reticulum in HeLa cells. | J Biol Chem | 2026 | 41856286 | PubTator, text mining | PubMed |
| Structural pharmacology of Chinese medicine: technological breakthroughs in decoding multi-target synergy and precision mechanisms. | Adv Biotechnol (Singap) | 2026 | 41824223 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7357/papers